DGAP-News: CompuGroup Medical SE Reports Results for First Quarter of 2019
DGAP-News: CompuGroup Medical SE / Key word(s): Quarter Results
CompuGroup Medical SE Reports Results for First Quarter of 2019
Koblenz, May 06, 2019 - CompuGroup Medical SE (CGM) today reported its financial results for the first quarter of 2019. The Koblenz-based company, one of the world's leading providers of eHealth solutions, generated a revenue of EUR 175 million compared to EUR 166 million in the same period of the previous year. Also favored by regulatory accounting changes, consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) and operating margin both rose to EUR 50 million and 28 percent in the first quarter of 2019, compared with EUR 39 million and 23 percent in the same period of the previous year.
The Pharmacy (Pharmacy Information Systems, PCS), Hospital (Hospital Information Systems, HIS) and Health Connectivity Services (HCS) segments grew more strongly than expected in the first quarter: In the PCS segment, CGM achieved an organic growth of 5 percent with established products and services as well as new opportunities through the implementation of the EU directive securPharm. The HIS segment with an organic growth of 10 percent is driven by the strong overall performance in the German-speaking DACH region (Germany, Austria, Switzerland) and a recovery of the hospital market in Poland.
"The overall strong performance in the first quarter gives us a positive outlook for the current year. I am particularly pleased with the good increase in recurring revenues from the business with doctors and dentists of almost 19 % compared with the same period of the previous year.," emphasizes Frank Gotthardt, CEO of CompuGroup Medical SE. "The growth in all of our segments shows that modern eHealth applications are becoming increasingly important across all sectors of the healthcare system. Our company is the driving force for intelligent networking among health professionals, involving all citizens. For no one should suffer or even die just because medical information is missing somewhere at some point."
CompuGroup Medical confirms the forecast for the fiscal year of 2019, which had been published with the 2018 Annual Report. Accordingly, the company expects consolidated revenues of between EUR 720 million and EUR 750 million for the current year and consolidated operating earnings (EBITDA) of between EUR 190 million and EUR 205 million.
Conference call for journalists, investors and analysts:
To participate in the conference call, please dial one of the following telephone numbers and enter the confirmation code:
+49 69 2017 4422 0 (Germany)
A presentation will be available for download on cgm.com/IR_Presentation prior to the conference call and can also be viewed live at: https://webcasts.eqs.com/compugroup20190506/no-audio
Contact for media representatives:
CompuGroup Medical SE
06.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
|Company:||CompuGroup Medical SE|
|Maria Trost 21|
|Phone:||+49 (0)261 8000 6200|
|Fax:||+49 (0)261 8000 3200|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||807257|
|End of News||DGAP News Service|
Nachrichten zu CompuGroup Medical SEmehr Nachrichten
||ANALYSE-FLASH: Kepler Cheuvreux startet Compugroup Medical mit 'Buy' (dpa-AFX)|
||CompuGroup-Aktie klettert trotz Abstufung auf Rekordhoch (dpa-AFX)|
||CompuGroup startet mit ordentlichem Wachstum ins Jahr - Aktie dennoch rot (dpa-AFX)|
||Compugroup: Florierende Geschäfte (ARD)|
||ANALYSE-FLASH: Baader Bank belässt Compugroup Medical auf 'Hold' - Ziel 53 Euro (dpa-AFX)|
||DGAP-News: CompuGroup Medical SE veröffentlicht Ergebnis für das erste Quartal 2019 (EQS Group)|